Antithrombotic Monotherapy or Combination Therapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Meta‐Analysis of Randomized Trials — Rohin K. Reddy (2025) | RDL Network
In patients with stable coronary artery disease and atrial fibrillation, oral anticoagulation monotherapy reduces major bleeding compared with dual antithrombotic therapy. There were no significant differences in all-cause and cardiovascular death, myocardial infarction, stroke, adverse cardiovascular events, and coronary revascularization.
Marco Valgimigli, Felice Gragnano, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo‐Yong Hahn, Qiang Zhao, Stephan Windecker, C. Michael Gibson, Byeong‐Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir R. Mehta, Sung‐Jin Hong, Kenji Andò, Hyeon‐Cheol Gwon, Patrick W. Serruys, ,
Ioanna Kosmidou, Shmuel Chen, A. Pieter Kappetein, Patrick W. Serruys, Bernard J. Gersh, John D. Puskas, David E. Kandzari, David P. Taggart, Marie‐Claude Morice, Paweł Buszman, Andrzej Bochenek, Erick Schampaert, Pierre Pagé, Joseph F. Sabik, Thomas McAndrew, Björn Redfors, Ori Ben‐Yehuda, Gregg W. Stone
Discussion(0)
No comments yet. Be the first to comment.